R&D and LICENSING
| THERAPEUTIC AREA | PHARMACEUTICAL FORM | EXPECTED LAUNCH |
|---|---|---|
| Ophthalmology/ Glaucoma | eye-drops | 2021 (IV) |
| Ophthalmology/ Glaucoma | eye-drops | 2024 |
| Ophthalmology/NSAIDs | eye-drops in gel | 2025 |
| Vascular disease (Hemorrhoids) | proctologic cream | 2020 (IV) |
| Vascular disease (Antithrombotic) | solution for injection | 2021 (II) |
| PATENT APPLICATION | PCT/IB2011/050663 | ||||
| TITLE DOCUMENT | TOPICAL CITICOLINE FOR THE TREATMENT OF GLAUCOMA |
||||
| APPLICATION NUMBER | PUBLICATION | STATUS | TITLE DOCUMENT HOLDER (PATENT HOLDER) |
||
| PCT | WO2011101802 | 25/08/2011 | OMIKRON ITALIA | ||
| NATIONAL STAGE | EUROPE EP2538918 |
02/01/2013 | GRANT OF PATENT IS INTENDED 06/06/2014 |
OMIKRON ITALIA | |
| NATIONAL STAGE | USA US8822429 |
13/12/2012 | GRANT OF PATENT IS INTENDED 13/08/2014 |
OMIKRON ITALIA | |
| NATIONAL STAGE | JAPAN JP5801324 |
04/09/2015 | GRANT OF PATENT IS INTENDED 18/08/2015 |
OMIKRON ITALIA |
| PATENT APPLICATION | PCT/IB2017/056400 | ||||
| TITLE DOCUMENT | OPHTHALMIC FORMULATION COMPRISING CITICOLINE CARRIED BY LIPOSOME FOR THE TREATMENT OF GLAUCOMA |
||||
| APPLICATION NUMBER | PUBLICATION | STATUS | TITLE DOCUMENT HOLDER (PATENT HOLDER) |
||
| PCT | WO2018073720 | 26/04/2018 | |||
| NATIONAL STAGE | USA US 10576039 |
16/04/2019 | GRANT OF PATENT IS INTENDED 03/03/2020 |
OMIKRON ITALIA |
| ABIOGEN PHARMA Pisa - Italy |
Glibenclamide + Meformin Hydrocloride (Diaglimet ®) RRR-α-tochoperol (Armilla ®) |
| URSAPHARM Arzneimittel GmbH Germany |
Retinol Palmitate (VitA-POS) |
